REMAIN-1: A phase 3 study of recaticimab monotherapy in dyslipidaemia

25 August 2023 (07:30 - 18:30)
Organised by: Logo
Congress Presentation Part of: Late-breaking science on pharmacology Lipid-Lowering Agents ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

ESC 365 is supported by

ESC 365 is supported by